Ferrer, F.; Chauvin, J.; DeVictor, B.; Lacarelle, B.; Deville, J.-L.; Ciccolini, J.
Clinical-Based vs. Model-Based Adaptive Dosing Strategy: Retrospective Comparison in Real-World mRCC Patients Treated with Sunitinib. Pharmaceuticals 2021, 14, 494.
https://doi.org/10.3390/ph14060494
AMA Style
Ferrer F, Chauvin J, DeVictor B, Lacarelle B, Deville J-L, Ciccolini J.
Clinical-Based vs. Model-Based Adaptive Dosing Strategy: Retrospective Comparison in Real-World mRCC Patients Treated with Sunitinib. Pharmaceuticals. 2021; 14(6):494.
https://doi.org/10.3390/ph14060494
Chicago/Turabian Style
Ferrer, Florent, Jonathan Chauvin, Bénédicte DeVictor, Bruno Lacarelle, Jean-Laurent Deville, and Joseph Ciccolini.
2021. "Clinical-Based vs. Model-Based Adaptive Dosing Strategy: Retrospective Comparison in Real-World mRCC Patients Treated with Sunitinib" Pharmaceuticals 14, no. 6: 494.
https://doi.org/10.3390/ph14060494
APA Style
Ferrer, F., Chauvin, J., DeVictor, B., Lacarelle, B., Deville, J.-L., & Ciccolini, J.
(2021). Clinical-Based vs. Model-Based Adaptive Dosing Strategy: Retrospective Comparison in Real-World mRCC Patients Treated with Sunitinib. Pharmaceuticals, 14(6), 494.
https://doi.org/10.3390/ph14060494